Sanofi SA
Find Ratings Reports
-0.35 |
-0.73%
SANOFI's gross profit margin for the first quarter of its fiscal year 2017 is essentially unchanged when compared to the same period a year ago. The company has grown its sales and net income during the past quarter when compared with the same quarter a year ago, and although its growth in net income has outpaced the industry average, its revenue growth has not.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
| Income Statement | Q1 FY17 | Q1 FY16 |
|---|---|---|
| Net Sales ($mil) | 9518.01 | 9029.99 |
| EBITDA ($mil) | 0.0 | 0.0 |
| EBIT ($mil) | 1949.18 | 1811.01 |
| Net Income ($mil) | 6098.93 | 1238.09 |
| Balance Sheet | Q1 FY17 | Q1 FY16 |
|---|---|---|
| Cash & Equiv. ($mil) | 0.0 | 0.0 |
| Total Assets ($mil) | 0.0 | 0.0 |
| Total Debt ($mil) | 0.0 | 0.0 |
| Equity ($mil) | 0.0 | 0.0 |
| Profitability | Q1 FY17 | Q1 FY16 |
|---|---|---|
| Gross Profit Margin | 63.04 | 63.53 |
| EBITDA Margin | 0.0 | 0.0 |
| Operating Margin | 20.48 | 20.06 |
| Sales Turnover | 0.0 | 0.0 |
| Return on Assets | 0.0 | 0.0 |
| Return on Equity | 0.0 | 0.0 |
| Debt | Q1 FY17 | Q1 FY16 |
|---|---|---|
| Current Ratio | 0.0 | 0.0 |
| Debt/Capital | 0.0 | 0.0 |
| Interest Expense | 118.75 | 146.93 |
| Interest Coverage | 16.41 | 12.33 |
| Share Data | Q1 FY17 | Q1 FY16 |
|---|---|---|
| Shares outstanding (mil) | 2543.88 | 2603.48 |
| Div / share | 0.0 | 0.0 |
| EPS | 0.53 | 0.44 |
| Book value / share | 0.0 | 0.0 |
| Institutional Own % | n/a | n/a |
| Avg Daily Volume | 1942004.0 | 1493810.0 |
BUY. The current P/E ratio indicates a significant discount compared to an average of 90.95 for the Pharmaceuticals industry and a value on par with the S&P 500 average of 24.66. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, SANOFI proves to trade at a discount to investment alternatives within the industry.
| Price/Earnings |
|
Price/Cash Flow |
| |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SNY 25.43 | Peers 90.95 | SNY NA | Peers 20.53 | |||||||||||||||||||||
|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations. SNY is trading at a significant discount to its peers. |
Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures. Ratio not available. |
|||||||||||||||||||||||
| Price/Projected Earnings |
|
Price to Earnings/Growth |
|
|||||||||||||||||||||
| SNY 14.09 | Peers 16.97 | SNY 0.33 | Peers 0.67 | |||||||||||||||||||||
|
Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations. SNY is trading at a discount to its peers. |
Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples. SNY trades at a significant discount to its peers. |
|||||||||||||||||||||||
| Price/Book |
|
Earnings Growth |
|
|||||||||||||||||||||
| SNY NA | Peers 12.00 | SNY 2.16 | Peers 18.85 | |||||||||||||||||||||
|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet. Ratio not available. |
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios. However, SNY is expected to significantly trail its peers on the basis of its earnings growth rate. |
|||||||||||||||||||||||
| Price/Sales |
|
Sales Growth |
|
|||||||||||||||||||||
| SNY 3.29 | Peers 11.85 | SNY -2.49 | Peers 6.08 | |||||||||||||||||||||
|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales. SNY is trading at a significant discount to its industry on this measurement. |
Lower. A sales growth rate that trails the industry implies that a company is losing market share. SNY significantly trails its peers on the basis of sales growth |
|||||||||||||||||||||||
